Literature DB >> 2644350

Analysis of human IgG and IgA subclass antibody-secreting cells from localized chronic inflammatory tissue.

T Ogawa1, A Tarkowski, M L McGhee, Z Moldoveanu, J Mestecky, H Z Hirsch, W J Koopman, S Hamada, J R McGhee, H Kiyono.   

Abstract

The chronic inflammatory diseases in humans have been intensively investigated, however the immune mechanisms underlying diseases such as rheumatoid arthritis (RA), inflammatory bowel disease, and periodontal disease (PD) remain elusive. In this study, we have analyzed the distribution of IgM, IgG, and IgA secreting cells with emphasis on the IgG and IgA subclasses among mononuclear cell populations isolated from gingiva at different stages of PD. Surgically removed tissues were treated with Dispase to gently dissociate cells and the Ficoll-Hypaque gradient centrifugation was used to enrich for viable mononuclear cells rich in lymphocytes, macrophages, and plasma cells. The total numbers of plasma cells increased with the severity of disease. Immunofluorescence analysis showed that most Ig-containing cells were of the IgG isotype; however, significant numbers of IgA-positive cells but few IgM-positive cells were seen. This isolation procedure allowed analysis, at the single cell level, of the distribution of IgG and IgA subclasses of antibody-secreting cells with monoclonal antibodies to human IgG and IgA subclasses. For this, we selected four monoclonal anti-IgG subclass (anti-gamma 1, -gamma 2, -gamma 3, and -gamma 4) antibodies with no subclass cross reactivity for use in the enzyme-linked immunospot assay. Analysis of slight, moderate, and advanced stages of PD showed a progressive increase in spotforming cells (SFC) numbers, and the major isotype of SFC was IgG followed by IgA. The major IgG subclass SFC seen was IgG1 followed by IgG2 whereas similar numbers of IgG3 and IgG4 SFC were observed, a pattern also seen with cells from synovium of RA patients and in mitogen-triggered spleen and PBMC. In terms of the IgA subclass distribution, IgA1 predominated in moderate stages, whereas a selective increase in IgA2 SFC were seen in the more advanced stage of PD. These results show that significant numbers of viable plasma cells/Ig-secreting cells can be isolated from inflamed gingival tissues. Further, careful analysis has shown that IgG subclass responses in gingiva are similar to those found in synovia of RA subjects, and in stimulated PBMC and spleen. However, it should be noted that the number of IgG4- and IgA2-secreting cells increased in the advanced stage of PD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2644350

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Cellular origins of human polymeric and monomeric IgA: enumeration of single cells secreting polymeric IgA1 and IgA2 in peripheral blood, bone marrow, spleen, gingiva and synovial tissue.

Authors:  A Tarkowski; Z Moldoveanu; W J Koopman; J Radl; J J Haaijman; J Mestecky
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

2.  An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivo.

Authors:  Scott M Baliban; Amanda Michael; Berje Shammassian; Shikata Mudakha; Amir S Khan; Simon Cocklin; Isaac Zentner; Brian P Latimer; Laurent Bouillaut; Meredith Hunter; Preston Marx; Niranjan Y Sardesai; Seth L Welles; Jeffrey M Jacobson; David B Weiner; Michele A Kutzler
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

3.  Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant.

Authors:  Noshin Kathuria; Kimberly A Kraynyak; Diane Carnathan; Michael Betts; David B Weiner; Michele A Kutzler
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

4.  Mucosal and systemic immune responses in BALB/c mice to Bacteroides gingivalis fimbriae administered orally.

Authors:  T Ogawa; H Shimauchi; S Hamada
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

5.  Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.

Authors:  F Qadri; F Ahmed; M M Karim; C Wenneras; Y A Begum; M Abdus Salam; M J Albert; J R McGhee
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

6.  Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis.

Authors:  K Fujihashi; J R McGhee; C Lue; K W Beagley; T Taga; T Hirano; T Kishimoto; J Mestecky; H Kiyono
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

7.  Differential use of immunoglobulin light chain genes and B lymphocyte expansion at sites of disease in rheumatoid arthritis (RA) compared with circulating B lymphocytes.

Authors:  S P Moyes; R N Maini; R A Mageed
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

8.  Lymphocyte subpopulation in healthy and diseased gingival tissue.

Authors:  Aniz Amunulla; Remya Venkatesan; Hemalatha Ramakrishnan; K V Arun; Subitha Sudarshan; Avaneendra Talwar
Journal:  J Indian Soc Periodontol       Date:  2008-05

9.  Splenic B-cell activation in lipopolysaccharide-non-responsive C3H/HeJ mice by lipopolysaccharide of Porphyromonas gingivalis.

Authors:  H Shimauchi; T Ogawa; H Uchida; J Yoshida; H Ogoh; T Nozaki; H Okada
Journal:  Experientia       Date:  1996-09-15

10.  Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo.

Authors:  Kimberly A Kraynyak; Michele A Kutzler; Neil J Cisper; Dominick J Laddy; Matthew P Morrow; Thomas A Waldmann; David B Weiner
Journal:  Hum Gene Ther       Date:  2009-10       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.